Guerbet SA (EPA:GBT)
France · Delayed Price · Currency is EUR 7.45
-0.05 (-0.67%)
Sep 11, 2026, 5:35 PM CET
Guerbet Market Cap
Guerbet has a market cap or net worth of €93.98 million as of September 11, 2026. Its market cap has decreased by -61.56% in one year.
Market Cap
93.98M
Enterprise Value
412.76M
Revenue
798.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.45
ChartMarket Cap Chart
Since March 3, 1992, Guerbet's market cap has decreased from 142.85M to 93.98M, a decrease of -34.21%. That is a compound annual growth rate of -1.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 93.98M | -47.84% |
| Dec 31, 2025 | 180.20M | -46.68% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 343.61M |
| Eurobio Scientific Société anonyme | 200.86M |
| Median Technologies | 151.32M |
| Theraclion | 51.18M |
| Novacyt | 36.40M |
| Mauna Kea Technologies | 30.74M |
| Diagnostic Medical Systems | 26.17M |
| Implanet | 24.88M |